About this Journal Submit a Manuscript Table of Contents
BioMed Research International
Volume 2013 (2013), Article ID 808391, 8 pages
http://dx.doi.org/10.1155/2013/808391
Research Article

Healthcare Utilization and Costs of Systemic Lupus Erythematosus in Medicaid

1U.S. Health Outcomes, GlaxoSmithKline, Research Triangle Park, NC 27709, USA
2Pharma, Truven Health Analytics Inc., Cambridge, MA 02140, USA
3Pharma, Truven Health Analytics Inc., Washington, DC 20008, USA
4European Market Access at Critical Disease Business Unit, GlaxoSmithKline, London TW8 9GS, UK
5Global Medical Affairs, GlaxoSmithKline, Philadelphia, PA 19102, USA

Received 26 June 2012; Revised 27 October 2012; Accepted 5 November 2012

Academic Editor: Veena K. Ranganath

Copyright © 2013 Hong J. Kan et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

How to Cite this Article

Hong J. Kan, Xue Song, Barbara H. Johnson, Benno Bechtel, Donna O'Sullivan, and Charles T. Molta, “Healthcare Utilization and Costs of Systemic Lupus Erythematosus in Medicaid,” BioMed Research International, vol. 2013, Article ID 808391, 8 pages, 2013. doi:10.1155/2013/808391